Tag: Nikolai Petrovsky
Advax(TM) (SMART 100)
Dr. Peter Cooper and Dr. Nikolai Petrovsky met at a social function in Canberra and realised that they shared a common interest in research into improved vaccines. From this initial research collaboration, Advax, a novel plant-sugar-based ingredient that enhances vaccine action, was born. Advax is now a leading ingredient in vaccines being developed in Australia, the US and Japan against pandemic influenza, HIV, malaria and a range of other infectious diseases.
"No entrepreneurs on new Commercialisation Australia board." What about marketers?
A privately initiated discussion has been gaining some momentum on the Anthill LinkedIn Group over the past week.
The discussion was triggered by an announcement from the Office of Senator Kim Carr, Australia's Minister for Innovation, pertaining to the selection of Commercialisation Australian board members.
“No entrepreneurs on new Commercialisation Australia board.” What about marketers?
A privately initiated discussion has been gaining some momentum on the Anthill LinkedIn Group over the past week.
The discussion was triggered by an announcement from the Office of Senator Kim Carr, Australia's Minister for Innovation, pertaining to the selection of Commercialisation Australian board members.
2009 Anthill Cool Company Awards winner profiles: Vaxine Pty Ltd (Coolest of the Cool)
For the second year running, Anthill's overall 'Coolest of the Cool' Award winner is an Australian medical company, combining the commercialisation of breakthrough research with the impact of saving lives globally. In the final analysis, our judges awarded overall honours to Vaxine Pty Ltd over the other 2009 Cool Company Awards category winners for its success to date in building a platform that will potentially benefit every human on Earth.
